Difference between revisions of "Pharm Meeting Agenda 2021.03.17"
Jump to navigation
Jump to search
| Line 13: | Line 13: | ||
===Change Proposals === | ===Change Proposals === | ||
:* [https://drive.google.com/file/d/1-48FLRY3BEnJuZ_nyz0Bfq1kFiOgWPYI/view?usp=sharing CP-PHARM-142] Proofreading / clarifications on CMPD, MTP, PADV profiles | :* [https://drive.google.com/file/d/1-48FLRY3BEnJuZ_nyz0Bfq1kFiOgWPYI/view?usp=sharing CP-PHARM-142] Proofreading / clarifications on CMPD, MTP, PADV profiles | ||
| − | :* CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile) | + | :* [https://drive.google.com/file/d/1WdPatA8OYpkD3uk0g1OeBHOrR-lfqBho/view?usp=sharing CP-PHARM-143] Align definitions of doseQuantity & rateQuantity (PRE profile) |
| − | :* CP-PHARM-144 Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles) | + | :* [https://drive.google.com/file/d/1hzA_L9iXVIy3sMWqzWHsJdSgMphGLy7G/view?usp=sharing CP-PHARM-144] Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles) |
| − | :* CP-PHARM-145 Cross-community PHARM-1 (CMPD profile) | + | :* [https://drive.google.com/file/d/1Yc4_QX9MaSEvYhNHE6gS5Hc3mJFUeOTE/view?usp=sharing CP-PHARM-145] Cross-community PHARM-1 (CMPD profile) |
| − | :* CP-PHARM-146 New MHD-based transaction PHARM-5 (CMPD profile) | + | :* [https://drive.google.com/file/d/1kko76AnrwaramEwPsHovwj6veCNgT6td/view?usp=sharing CP-PHARM-146] New MHD-based transaction PHARM-5 (CMPD profile) |
| − | :* CP-PHARM-147 moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles) | + | :* [https://drive.google.com/file/d/1ejY288pLJOJVhVZkQmmvPklkDYGvxwgi/view?usp=sharing CP-PHARM-147] moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles) |
For information only: | For information only: | ||
| − | :* CP-ITI-xxx "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling | + | :* [https://drive.google.com/file/d/1QwnGshWO9LYXLAZ9BY2-unaLBMbbZ4sL/view?usp=sharing CP-ITI-xxx] "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling |
| − | :* CP-PCC-xxx Order of approachSiteCode, doseQuantity and rateQuantity varies --> may impact IHE PRE & MTP profiles | + | :* [https://drive.google.com/file/d/1VcJBTO8JJh1winqBmOqmZVj7ghv9MPg6/view?usp=sharing CP-PCC-xxx] Order of approachSiteCode, doseQuantity and rateQuantity varies --> may impact IHE PRE & MTP profiles |
=== Medication lists === | === Medication lists === | ||
Revision as of 02:42, 15 March 2021
Meeting details
Location
Agenda
Q1 13:00- 14:30 Change proposals & Medication Lists
Change Proposals
- CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles
- CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile)
- CP-PHARM-144 Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
- CP-PHARM-145 Cross-community PHARM-1 (CMPD profile)
- CP-PHARM-146 New MHD-based transaction PHARM-5 (CMPD profile)
- CP-PHARM-147 moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles)
For information only:
- CP-ITI-xxx "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling
- CP-PCC-xxx Order of approachSiteCode, doseQuantity and rateQuantity varies --> may impact IHE PRE & MTP profiles